199 related articles for article (PubMed ID: 15888747)
1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT).
Huddart RA; Purkalne G;
Ann Oncol; 2005; 16 Suppl 1():i37-9. PubMed ID: 15888747
[No Abstract] [Full Text] [Related]
2. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT).
Ann Oncol; 2001 Sep; 12(9):1215-6. PubMed ID: 11697829
[No Abstract] [Full Text] [Related]
3. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Huddart RA
Ann Oncol; 2007 Apr; 18 Suppl 2():ii42-3. PubMed ID: 17491041
[No Abstract] [Full Text] [Related]
4. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
McKendrick JJ; Mead GM; Cowlishaw D
Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050
[No Abstract] [Full Text] [Related]
5. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
6. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
Powles T
Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
[TBL] [Abstract][Full Text] [Related]
7. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
Krege S; Rübben H
Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
[TBL] [Abstract][Full Text] [Related]
8. Staging and prognostic factors in nonseminomatous testicular cancer.
Murphy P; Johnson DH
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1233-43. PubMed ID: 1663942
[TBL] [Abstract][Full Text] [Related]
9. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
10. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Huddart R; Kataja V;
Ann Oncol; 2008 May; 19 Suppl 2():ii52-4. PubMed ID: 18456768
[No Abstract] [Full Text] [Related]
11. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
12. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
13. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
14. [Chemotherapeutic treatment regimens for germinal testicular tumors].
Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
[No Abstract] [Full Text] [Related]
15. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
16. [Current status of the diagnosis and therapy of germinal testicular tumors].
Gorski J
Z Arztl Fortbild (Jena); 1987; 81(20):1065-9. PubMed ID: 2829451
[No Abstract] [Full Text] [Related]
17. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
18. The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Pokrivcak T; Lakomy R; Kazda T; Poprach A; Fabian P; Kiss I
Medicine (Baltimore); 2021 Jun; 100(24):e26381. PubMed ID: 34128899
[TBL] [Abstract][Full Text] [Related]
19. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
20. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
[Next] [New Search]